ZANAGLIO, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.786
AS - Asia 868
EU - Europa 773
SA - Sud America 130
AF - Africa 25
OC - Oceania 3
Totale 3.585
Nazione #
US - Stati Uniti d'America 1.747
SG - Singapore 391
CN - Cina 237
IT - Italia 207
DE - Germania 114
BR - Brasile 101
UA - Ucraina 98
FI - Finlandia 88
VN - Vietnam 60
HK - Hong Kong 59
FR - Francia 57
GB - Regno Unito 38
TR - Turchia 33
SE - Svezia 32
RU - Federazione Russa 30
IE - Irlanda 29
IN - India 25
CA - Canada 24
CZ - Repubblica Ceca 18
IQ - Iraq 13
JP - Giappone 11
PL - Polonia 11
AR - Argentina 10
BD - Bangladesh 10
NL - Olanda 10
ZA - Sudafrica 10
BE - Belgio 9
MX - Messico 8
ES - Italia 7
AT - Austria 6
VE - Venezuela 6
JO - Giordania 5
UZ - Uzbekistan 4
EC - Ecuador 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
ET - Etiopia 2
HN - Honduras 2
KG - Kirghizistan 2
KR - Corea 2
LV - Lettonia 2
PY - Paraguay 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.585
Città #
Singapore 220
Ashburn 193
Fairfield 193
Chandler 107
San Jose 107
Seattle 77
Jacksonville 75
New York 73
Woodbridge 70
Wilmington 69
Ann Arbor 66
Beijing 65
Helsinki 62
Hong Kong 58
Houston 55
Cambridge 54
Princeton 51
Munich 49
Brescia 44
Los Angeles 39
The Dalles 38
Dallas 29
Dublin 27
Lauterbourg 27
Des Moines 26
Turku 23
Istanbul 22
Shanghai 22
Ho Chi Minh City 16
Boardman 15
Buffalo 15
Brno 14
Chicago 14
Hanoi 13
Moscow 13
Santa Clara 13
Denver 12
Orem 11
Pune 11
São Paulo 11
Montreal 10
Tokyo 10
Warsaw 10
Brooklyn 9
Brussels 9
Nanjing 9
Rome 9
San Francisco 9
Stockholm 9
Shenyang 8
Toronto 8
Johannesburg 7
Milan 7
Redondo Beach 7
Boston 6
Genoa 6
Jinan 6
London 6
San Diego 6
Tianjin 6
Amman 5
Bosio 5
Charlotte 5
Da Nang 5
Darfo 5
Kocaeli 5
Paris 5
Rio de Janeiro 5
Amsterdam 4
Atlanta 4
Baghdad 4
Battipaglia 4
Changsha 4
Chennai 4
Council Bluffs 4
Frankfurt am Main 4
Manchester 4
Mexico City 4
Phoenix 4
Tashkent 4
Alzano Lombardo 3
Bergamo 3
Bologna 3
Brendola 3
Dearborn 3
Dhaka 3
Düsseldorf 3
Guangzhou 3
Haiphong 3
Nuremberg 3
Olomouc 3
Poplar 3
Viterbo 3
Ancona 2
Athens 2
Augusta 2
Baku 2
Bauru 2
Betim 2
Bishkek 2
Totale 2.397
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 205
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 198
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 172
Advances in CMV Management: A Single Center Real-Life Experience 168
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 167
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 167
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 160
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 154
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 152
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 149
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 137
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 137
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 135
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 134
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 129
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 126
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 124
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 123
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 121
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 119
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 103
dsDNA from extracellular vesicles (EVs) in adult AML 99
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 96
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 80
Totale 3.634
Categoria #
all - tutte 17.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 0 0 0 0 77 40 30
2021/2022265 21 15 3 26 14 25 11 20 14 45 16 55
2022/2023292 38 15 12 20 22 54 2 49 44 7 16 13
2023/2024308 17 4 35 16 19 85 11 9 46 1 4 61
2024/2025647 13 18 0 94 56 52 33 33 104 41 125 78
2025/20261.202 120 115 66 194 152 98 214 54 71 118 0 0
Totale 3.634